Tesla, General Motors, Alibaba, and More: Why These Stocks Are in the Spotlight
The extended weekend is now over, and Wall Street is once again paying attention to the U.S. China trade war, the Indian stock market now that Modi has...
Posts Tagged ‘Astrazeneca Plc (AZN)’
Billionaire Ken Fisher is Bullish About These Dividend Stocks
Fisher Investments was founded in 1979 by billionaire Ken Fisher. The fee-only investment adviser managed more than $100 billion in assets as of July...
Hedge Fund and Insider Trading News: Daniel Loeb, Tom Steyer, Ray Dalio, AstraZeneca PLC (AZN), Alteryx Inc (AYX), and More
Dan Loeb’s Hedge Fund Trims Number of Nominees to Campbell Soup Board (CNBC) Daniel Loeb‘s hedge fund, Third Point, has trimmed the number...
Druckenmiller’s 4Q13 Portfolio Changes
Stan Druckenmiller is a billionaire, and was the long-time manager of Duquesne Capital. Now, he oversees a family office, but his investing strategy is...
Everything You Need to Know About the Upcoming Flu Season
To me, flu season is a lot like Christmas; there’s a defined time period when we expect it to occur, yet it seems to appear earlier and earlier...
An Excellent Investment in the Biotech Space?
According to the American Cancer Society, more than 60,000 new cases of thyroid cancer will be diagnosed in the U.S., and about 1,850 people are expected...
Johnson & Johnson (JNJ), AstraZeneca plc (ADR) (AZN), The Procter & Gamble Company (PG): The Priceless Health Business Every Investor Overlooks
Investors know Johnson & Johnson (NYSE:JNJ) for many things. It’s arguably health care’s biggest name. The company’s pharmaceutical...
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc...
AstraZeneca plc (ADR) (AZN), Merck & Co., Inc. (MRK), Endocyte, Inc. (ECYT): Three Things You Need to Know About This Big Pharma Deal
Two big pharmaceutical players on opposite sides of the Atlantic have forged yet another bond. Through the years, London-based drugmaker AstraZeneca plc...
Omthera Pharmaceuticals Inc (OMTH), Elan Corporation, plc (ADR) (ELN), Onyx Pharmaceuticals, Inc. (ONXX): 3 Big Biotech Buyouts of 2013
The Chinese calendar says 2013 is the year of the snake, but the market says it’s the year of biotech. Major biotechnology ETFs and indices have...
GlaxoSmithKline plc (ADR) (GSK), Theravance Inc (THRX), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Could a Pair of Respiratory Disease Treatments Save This Big Pharma?
GlaxoSmithKline plc (ADR) (NYSE:GSK) and its partner Theravance Inc (NASDAQ:THRX) recently scored a second victory in their quest to treat chronic obstructive...
Bristol Myers Squibb Co. (BMY), Merck & Co., Inc. (MRK): Is AstraZeneca plc (ADR) (AZN)’s Recent Acquisition Bigger Than Onyx?
AstraZeneca plc (ADR) (NYSE:AZN) may have missed out on acquiring the oncology platform of Onyx Pharmaceuticals, but it responded by pulling the trigger...
Theravance Inc (THRX), GlaxoSmithKline plc (ADR) (GSK): Time to Bet on This Biotech Spinoff?
There hasn’t been a dull moment for investors of Theravance Inc (NASDAQ:THRX) since the company submitted an NDA for COPD/asthma drug BREO before...
AbbVie Inc (ABBV), AstraZeneca plc (ADR) (AZN): Neurocrine Biosciences, Inc. (NBIX) Nosedives on Mid-Stage Study Results
Investors hate to wake up and find that one of their stocks has opened nearly 30% lower than the prior day’s close. Unfortunately, that’s...
Dendreon Corporation (DNDN), ISIS Pharmaceuticals, Inc. (ISIS): Big Milestones Could Lead This Stock to Big Gains
I cannot emphasize enough how important having a deep and diverse pipeline, as well as numerous potential collaborative partners, can be in the biotechnology...
ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)
Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years. The pair announced...
AstraZeneca plc (ADR) (AZN), Bristol Myers Squibb Co. (BMY), GlaxoSmithKline plc (ADR) (GSK): Diabetes Drugmakers and Their “Definitely Maybe” Moment
Over the past decade, the Food and Drug Administration has taken multiple steps to improve the process by which drugs are developed and eventually brought...
AstraZeneca plc (ADR) (AZN), BlackBerry Ltd (BBRY): Tuesday’s Top Upgrades (and Downgrades)
This series, brought to you by Yahoo! Finance, looks at which upgrades and downgrades make sense, and which ones investors should act on. Today, our headlines...
AstraZeneca plc (ADR) (AZN), Bristol-Myers Squibb Co (BMY), BioMarin Pharmaceutical Inc. (BMRN): Three PDUFA Dates That Will Kick Off 2014
The phrase “PDUFA date” is thrown around frequently when discussing biotech and pharma companies. PDUFA stands for the Prescription Drug User...
Alkermes Plc (ALKS), Eli Lilly & Co. (LLY), AstraZeneca plc (ADR) (AZN): Tackling Pain and Addiction
Alkermes Plc (NASDAQ:ALKS) is primarily known for its schizophrenia and multiple sclerosis drug treatments. Schizophrenia treatments Risperdal Consta...
Amgen, Inc. (AMGN), AstraZeneca plc (ADR) (AZN): What’s the Big Deal About Onyx Pharmaceuticals, Inc. (ONXX) Anyway?
At the end of June, Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) announced that it had rejected an offer from Amgen, Inc. (NASDAQ:AMGN) that valued the...
AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY), MannKind Corporation (MNKD): Three New Diabetes Drugs Possibly on the Way Soon
It’s no wonder that plenty of companies are developing diabetes drugs. There are more than 370 million people with diabetes worldwide. The global...
Osiris Therapeutics, Inc. (OSIR), Anacor Pharmaceuticals Inc (ANAC), Novavax, Inc. (NVAX): Three Humongous Health-Care Stocks This Week
A rising tide lifts all boats, but the opposite isn’t true in the stock market. The major indexes slipped this week, while a handful of health-care...
GlaxoSmithKline plc (ADR) (GSK), Novartis AG (ADR) (NVS): This Company’s Debt Might Be a Concern
GlaxoSmithKline plc (ADR) (NYSE:GSK) has been accused of making illegal payments to Chinese doctors and government officials by siphoning them through...
MannKind Corporation (MNKD), Novo Nordisk A/S (ADR) (NVO), Eli Lilly & Co. (LLY): A Good Drug That’s Too Risky to Buy
In a companion article a few days ago, I predicted that MannKind Corporation (NASDAQ:MNKD)‘s extended phase 3 program for its inhaled insulin,...
Medidata Solutions Inc (MDSO), salesforce.com, inc. (CRM): I’m Buying This High-Flying Stock Now
Every month, I select one or more stocks that I’ll be buying in real life for my Roth IRA. I’ve been doing this for over two years, and &#...
Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
As human beings it can sometimes be difficult for us to see the good in a bad situation. In the biotech sector, where developing a drug can cost hundreds...
Teva Pharmaceutical Industries Ltd (ADR) (TEVA), AstraZeneca plc (ADR) (AZN): A Safe Investment With Growth Promise
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been stuck is share purgatory for a number of years. There have been no capital gains, and the...
3 Things You Need to Know From Astex Pharmaceuticals, Inc. (ASTX)’s Q2 Earnings
Astex Pharmaceuticals, Inc. (NASDAQ:ASTX) announced its second-quarter financial results on Thursday prior to the market open. The company reported a...
Three Things You Need to Know From Keryx Biopharmaceuticals (KERX)’s Q2 Earnings
Keryx Biopharmaceuticals (NASDAQ:KERX) announced its second-quarter results before the market opened on Thursday. Shares fell slightly as investors reacted...
Array Biopharma Inc (ARRY), AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): This Cancer Biotech Is Looking for Other Green Pastures
Array Biopharma Inc (NASDAQ:ARRY), a biotech company primarily focused on discovery of drugs for cancer treatment, is making forays into the asthma market...
China Petroleum & Chemical Corp (ADR) (SNP), AstraZeneca plc (ADR) (AZN): Three Companies With Dividend Yields You Don’t Want to Miss
Several companies are striving hard to manage their business and retain investors by providing an attractive dividend. These days, investors prefer a...
Three Things You Need to Know From Merck & Co., Inc. (MRK)’s Q2 Earnings
Merck & Co., Inc. (NYSE:MRK) announced its second quarter financial results prior to the market open on Tuesday. Here are the most important things...
AstraZeneca plc (ADR) (AZN) and Bristol Myers Squibb Co. (BMY): 2 Keys to Success for This Diabetes Drug’s Second Chance
If at first you don’t succeed, try, try again. We’ve heard that old saw many times, but it’s good advice. It’s also advice that...
Bristol Myers Squibb Co. (BMY), AstraZeneca plc (ADR) (AZN): Expanding P/E Saved This Pharma Investment
So much for Bristol Myers Squibb Co. (NYSE:BMY)‘s long-term post-Plavix guidance. Three years ago, the company told investors not to worry. It...
Onyx Pharmaceuticals, Inc. (ONXX), Amgen, Inc. (AMGN): Will This Biotech Bidding War Lead You to Larger Gains?
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) added 3% to its one-month 60% gains on Monday because of continued speculation of a buyout. Reportedly, four...
Pfizer Inc. (PFE), GlaxoSmithKline plc (ADR) (GSK): Three Healthcare Stocks for Growth and Dividends
The healthcare sector has been one of the best sectors for dividend hunters — most of the companies operating in the sector generate massive cash...
AstraZeneca plc (ADR) (AZN), Eli Lilly & Co. (LLY): The Diabetes Pipeline With a Clog
Big pharma placed its bets on a new class of diabetes drugs called SGLT2. Last year, buzz surrounded late-stage projects from Johnson and Johnson (NYSE...
Four Potential Suitors for Onyx Pharmaceuticals, Inc. (ONXX)
The “people familiar with the matter” are out in full force spouting off about who’s bidding for Onyx Pharmaceuticals, Inc. (NASDAQ...
AstraZeneca plc (ADR) (AZN), Actavis Inc (ACT): Can Fish Oil Help This Drug Giant Regain its Mojo?
AstraZeneca plc (ADR) (NYSE:AZN)’s financial results have been on a downward spiral lately, as patent expirations have led to sharp declines in sales...
Amarin Corporation plc (ADR) (AMRN) Shares Sink on Secondary Offering
“More means less.” Amarin Corporation plc (ADR) (NASDAQ:AMRN) demonstrated this seemingly contradictory maxim today following its announcement...
The Medicines Company (MDCO), AstraZeneca plc (ADR) (AZN): A Small-Cap Pharmaceutical Company With 2014 in Its Sights
A few months back, Barron’s featured an intriguing pharmaceutical company that goes by the name The Medicines Company (NASDAQ:MDCO). This stock...
How Much Is Onyx Pharmaceuticals, Inc. (ONXX) Really Worth?
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) is having a garage sale, but it doesn’t appear that Amgen, Inc. (NASDAQ:AMGN) has been invited. The promising...
TAL International Group, Inc. (TAL), Annaly Capital Management, Inc. (NLY) – High Yield: Stocks or Bonds?
A few weeks ago, CAPS player Valyooo started a lively debate with a blog entry asking for opinions on stocks vs. high-yield bonds. Since then, the Fed...
AstraZeneca plc (ADR) (AZN), PDL BioPharma Inc. (PDLI): Tempting Healthcare Dividend Stocks to Avoid
When screening for health-care dividend stocks, it’s tempting to look for the ones with the highest yield. On the surface, larger dividend payments...
ISIS Pharmaceuticals, Inc. (ISIS): This Anti-Sense Bet Makes Sense
In the last couple of years, the biotechnology industry has been on a roll. The large number of drug approvals and the dreaded patent cliff has positively...
Merck & Co., Inc. (MRK) Stock Depends on Januvia More Than Ever
Merck & Co., Inc. (NYSE:MRK) stock has become dependent on its diabetes drug Januvia over the past couple of years for revenue growth. The franchise...
AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY): Don’t Ignore These European Healthcare Stocks
Healthcare stocks have rallied over the past couple years, and for good reason. Not only is the global economy gaining traction, but the demographic trends...
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN), Omthera Pharmaceuticals Inc (OMTH): Three Stocks Near 52-Week Lows Worth Buying
Just as we examine companies each week that may be rising past their fair value, we can also find companies potentially trading at bargain prices. While...
What These Ratios Tell Us About GlaxoSmithKline plc (ADR) (GSK)
LONDON — Before I decide whether to buy a company’s shares, I always like to look at two core financial ratios — return on equity ...
